Literature DB >> 19033653

Autophagy-induced tumor dormancy in ovarian cancer.

Ravi K Amaravadi1.   

Abstract

Autophagy--a process of "self-eating" that involves enzymatic digestion and recycling of cellular constituents in response to stress--contributes to both cancer cell death and survival. In this issue of the JCI, Lu et al. report that controlled induction of tumor suppressor gene aplasia Ras homolog member I (ARHI) results in autophagic cell death of human ovarian cancer cells in vitro (see the related article beginning on page 3917). However, within xenograft tumors in mice, multiple factors within the tumor microenvironment switched ARHI-induced autophagy to a mechanism of tumor cell survival, leading to tumor dormancy. Since ARHI expression is suppressed in the majority of breast and ovarian cancers but is high in premalignant lesions, ARHI-induced autophagy could be manipulated for therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19033653      PMCID: PMC2582935          DOI: 10.1172/JCI37667

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Autophagy suppresses tumor progression by limiting chromosomal instability.

Authors:  Robin Mathew; Sameera Kongara; Brian Beaudoin; Cristina M Karp; Kevin Bray; Kurt Degenhardt; Guanghua Chen; Shengkan Jin; Eileen White
Journal:  Genes Dev       Date:  2007-05-17       Impact factor: 11.361

Review 2.  Autophagy fights disease through cellular self-digestion.

Authors:  Noboru Mizushima; Beth Levine; Ana Maria Cuervo; Daniel J Klionsky
Journal:  Nature       Date:  2008-02-28       Impact factor: 49.962

3.  Autophagy delays apoptotic death in breast cancer cells following DNA damage.

Authors:  M J Abedin; D Wang; M A McDonnell; U Lehmann; A Kelekar
Journal:  Cell Death Differ       Date:  2006-09-22       Impact factor: 15.828

4.  Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis.

Authors:  Yoshinori Takahashi; Domenico Coppola; Norimasa Matsushita; Hernani D Cualing; Mei Sun; Yuya Sato; Chengyu Liang; Jae U Jung; Jin Q Cheng; James J Mulé; W Jack Pledger; Hong-Gang Wang
Journal:  Nat Cell Biol       Date:  2007-09-23       Impact factor: 28.824

5.  Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

Authors:  Jiuhong Yuan; Robert Z Luo; Satoshi Fujii; Lin Wang; Wei Hu; Michael Andreeff; Yong Pan; Mitsutaka Kadota; Mitsuo Oshimura; Aysegul A Sahin; Jean-Pierre Issa; Robert C Bast; Yinhua Yu
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

6.  Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.

Authors:  Kirsteen H Maclean; Frank C Dorsey; John L Cleveland; Michael B Kastan
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 7.  The roles of therapy-induced autophagy and necrosis in cancer treatment.

Authors:  Ravi K Amaravadi; Craig B Thompson
Journal:  Clin Cancer Res       Date:  2007-12-15       Impact factor: 12.531

8.  The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells.

Authors:  Zhen Lu; Robert Z Luo; Yiling Lu; Xuhui Zhang; Qinghua Yu; Shilpi Khare; Seiji Kondo; Yasuko Kondo; Yinhua Yu; Gordon B Mills; Warren S-L Liao; Robert C Bast
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

9.  Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance.

Authors:  Jennifer S Carew; Steffan T Nawrocki; Charissa N Kahue; Hui Zhang; Chunying Yang; Linda Chung; Janet A Houghton; Peng Huang; Francis J Giles; John L Cleveland
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

10.  p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy.

Authors:  Serhiy Pankiv; Terje Høyvarde Clausen; Trond Lamark; Andreas Brech; Jack-Ansgar Bruun; Heidi Outzen; Aud Øvervatn; Geir Bjørkøy; Terje Johansen
Journal:  J Biol Chem       Date:  2007-06-19       Impact factor: 5.157

View more
  27 in total

1.  Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress.

Authors:  Jianping Kong; Kelly A Whelan; Dorottya Laczkó; Brendan Dang; Angeliz Caro Monroig; Ali Soroush; John Falcone; Ravi K Amaravadi; Anil K Rustgi; Gregory G Ginsberg; Gary W Falk; Hiroshi Nakagawa; John P Lynch
Journal:  Mol Carcinog       Date:  2015-09-16       Impact factor: 4.784

2.  Cancer risk in systemic lupus: an updated international multi-centre cohort study.

Authors:  Sasha Bernatsky; Rosalind Ramsey-Goldman; Jeremy Labrecque; Lawrence Joseph; Jean-Francois Boivin; Michelle Petri; Asad Zoma; Susan Manzi; Murray B Urowitz; Dafna Gladman; Paul R Fortin; Ellen Ginzler; Edward Yelin; Sang-Cheol Bae; Daniel J Wallace; Steven Edworthy; Soren Jacobsen; Caroline Gordon; Mary Anne Dooley; Christine A Peschken; John G Hanly; Graciela S Alarcón; Ola Nived; Guillermo Ruiz-Irastorza; David Isenberg; Anisur Rahman; Torsten Witte; Cynthia Aranow; Diane L Kamen; Kristjan Steinsson; Anca Askanase; Susan Barr; Lindsey A Criswell; Gunnar Sturfelt; Neha M Patel; Jean-Luc Senécal; Michel Zummer; Janet E Pope; Stephanie Ensworth; Hani El-Gabalawy; Timothy McCarthy; Lene Dreyer; John Sibley; Yvan St Pierre; Ann E Clarke
Journal:  J Autoimmun       Date:  2013-02-12       Impact factor: 7.094

3.  Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.

Authors:  Xiaoyan Liang; Michael E De Vera; William J Buchser; Antonio Romo de Vivar Chavez; Patricia Loughran; Donna Beer Stolz; Per Basse; Tao Wang; Bennett Van Houten; Herbert J Zeh; Michael T Lotze
Journal:  Cancer Res       Date:  2012-04-03       Impact factor: 12.701

4.  Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells.

Authors:  Xuejiao Zhao; Yong Fang; Yang Yang; Yu Qin; Peng Wu; Ting Wang; Huiling Lai; Li Meng; Daowen Wang; Zhihui Zheng; Xinhua Lu; Hua Zhang; Qinglei Gao; Jianfeng Zhou; Ding Ma
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

5.  Enhanced antitumor effect of lower-dose and longer-term CPT-11 treatment in combination with low-dose celecoxib against neuroblastoma xenografts.

Authors:  Setsuko Kaneko; Michio Kaneko; Takashi Fukushima
Journal:  Int J Clin Oncol       Date:  2011-12-01       Impact factor: 3.402

Review 6.  Mechanisms of Cancer Cell Dormancy--Another Hallmark of Cancer?

Authors:  Albert C Yeh; Sridhar Ramaswamy
Journal:  Cancer Res       Date:  2015-09-09       Impact factor: 12.701

7.  Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.

Authors:  Daina Z Ewton; Jing Hu; Maria Vilenchik; Xiaobing Deng; Kin-Chun Luk; Ann Polonskaia; Ann F Hoffman; Karen Zipf; John F Boylan; Eileen A Friedman
Journal:  Mol Cancer Ther       Date:  2011-08-30       Impact factor: 6.261

8.  Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab.

Authors:  Alejandro Vazquez-Martin; Cristina Oliveras-Ferraros; Javier A Menendez
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

Review 9.  Malignancies in systemic lupus erythematosus.

Authors:  Emese Kiss; Laszlo Kovacs; Peter Szodoray
Journal:  Autoimmun Rev       Date:  2009-07-27       Impact factor: 9.754

10.  Breast cancer in systemic lupus.

Authors:  S Bernatsky; R Ramsey-Goldman; M Petri; M B Urowitz; D D Gladman; P R Fortin; E Ginzler; J Romero-Diaz; C Peschken; S Jacobsen; J G Hanly; C Gordon; O Nived; E H Yelin; D Isenberg; A Rahman; S-C Bae; L Joseph; T Witte; G Ruiz-Irastorza; C Aranow; D Kamen; G Sturfeldt; W D Foulkes; J E Hansen; Y St Pierre; P Chrétien Raymer; B Tessier-Cloutier; A E Clarke
Journal:  Lupus       Date:  2016-09-30       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.